{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:50:03Z","timestamp":1791301803224,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.anai.2025.07.030","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:15:30Z","timestamp":1754579730000},"page":"521-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mast cell conditions and drug allergy"],"prefix":"10.1016","volume":"135","author":[{"given":"Bianca","family":"Olivieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.anai.2025.07.030_bib0001","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jaip.2022.05.007","article-title":"Global classification of mast cell activation disorders: an ICD-10-CM-adjusted proposal of the ECNM-AIM consortium","volume":"10","author":"Valent","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.anai.2025.07.030_bib0002","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"14","key":"10.1016\/j.anai.2025.07.030_bib0003","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.3390\/cancers14143474","article-title":"Systemic mastocytosis and other entities involving mast cells: a practical review and update","volume":"14","author":"El Hussein","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.anai.2025.07.030_bib0004","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41375-021-01406-y","article-title":"Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis","volume":"36","author":"Zanotti","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.anai.2025.07.030_bib0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2025.07.030_bib0006","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2025.07.030_bib0007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience","volume":"44","author":"G\u00fclen","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.anai.2025.07.030_bib0008","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonz\u00e1lez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.anai.2025.07.030_bib0009","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1081-1206(10)61086-1","article-title":"Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group","volume":"97","author":"Lieberman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.07.030_bib0010","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/all.16132","article-title":"Prevalence of hypersensitivity reactions in various forms of mastocytosis: a pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry","volume":"79","author":"Niedoszytko","year":"2024","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2025.07.030_bib0011","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2022.09.004","article-title":"MRGPRX2 in drug allergy: what we know and what we do not know","volume":"151","author":"Kolkhir","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"7542","key":"10.1016\/j.anai.2025.07.030_bib0012","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.anai.2025.07.030_bib0013","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11882-024-01183-5","article-title":"Mast cells and mas-related G protein-coupled receptor X2: itching for novel pathophysiological insights to clinical relevance","volume":"25","author":"Castells","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2025.07.030_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676354","article-title":"MRGPRX2 and adverse drug reactions","volume":"12","author":"McNeil","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.07.030_bib0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaip.2022.11.001","article-title":"Patient characteristics associated with reactions to Mrgprx2-activating drugs in an electronic health record-linked Biobank","volume":"11","author":"Foer","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.07.030_bib0016","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ACI.0000000000001001","article-title":"Mast cell conditions and drug allergy: when to suspect and how to manage","volume":"24","author":"Olivieri","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.07.030_bib0017","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.iac.2023.04.002","article-title":"Drug and venom allergy in mastocytosis","volume":"43","author":"Giannetti","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.anai.2025.07.030_bib0018","first-page":"1","article-title":"Challenges in drug and Hymenoptera venom hypersensitivity diagnosis and management in mastocytosis","volume":"14","author":"Giannetti","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"10.1016\/j.anai.2025.07.030_bib0019","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jaip.2024.03.040","article-title":"Drug-induced anaphylaxis uncommon in mastocytosis: findings from two large cohorts","volume":"12","author":"Beyens","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2025.07.030_bib0020","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaip.2024.10.039","article-title":"Demographics, types of patient-reported allergic diseases, and anaphylaxis in mastocytosis: a single-center US experience","volume":"13","author":"Kaakati","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2025.07.030_bib0021","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jaci.2018.10.063","article-title":"Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: a Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology","volume":"143","author":"Carter","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.07.030_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.1071807","article-title":"Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: a two-center retrospective cohort study","volume":"3","author":"Bonadonna","year":"2022","journal-title":"Front Allergy"},{"issue":"3","key":"10.1016\/j.anai.2025.07.030_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12132","article-title":"Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features","volume":"12","author":"Rama","year":"2022","journal-title":"Clin Transl Allergy"},{"issue":"10","key":"10.1016\/j.anai.2025.07.030_bib0024","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/all.13445","article-title":"Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: the results of a double-blind, placebo-controlled challenge study","volume":"73","author":"Hermans","year":"2018","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.anai.2025.07.030_bib0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/all.12617","article-title":"Drug hypersensitivity in clonal mast cell disorders: ENDA\/EAACI position paper","volume":"70","author":"Bonadonna","year":"2015","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.07.030_bib0026","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s40521-023-00349-2","article-title":"Triggers of anaphylaxis in mastocytosis patients: evidence of the current drug \u2011 avoidance recommendation","volume":"10","author":"Rama","year":"2023","journal-title":"Curr Treat Options Allergy"},{"issue":"6","key":"10.1016\/j.anai.2025.07.030_bib0027","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1086\/591126","article-title":"Emergency department visits for antibiotic-associated adverse events","volume":"47","author":"Shehab","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.anai.2025.07.030_bib0028","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.anai.2025.07.030_bib0029","doi-asserted-by":"crossref","first-page":"778.e1","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: age and sex effects","volume":"122","author":"Macy","year":"2009","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.anai.2025.07.030_bib0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2500\/aap.2014.35.3791","article-title":"Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population","volume":"35","author":"Albin","year":"2014","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"10.1016\/j.anai.2025.07.030_bib0031","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.14122","article-title":"Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper","volume":"75","author":"Romano","year":"2020","journal-title":"Allergy"},{"issue":"13","key":"10.1016\/j.anai.2025.07.030_bib0032","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.3390\/diagnostics13132241","article-title":"Diagnostic evaluation of hypersensitivity reactions to antibiotics in a large cohort of mastocytosis patients","volume":"13","author":"Jarkvist","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.anai.2025.07.030_bib0033","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.intimp.2019.02.001","article-title":"Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent","volume":"70","author":"Liu","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.anai.2025.07.030_bib0034","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jaip.2019.01.059","article-title":"Anaphylaxis to quinolones in mastocytosis: hypothesis on the mechanism","volume":"7","author":"Giavina-Bianchi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2025.07.030_bib0035","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1016\/j.jaip.2021.05.042","article-title":"Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis","volume":"9","author":"Deepak","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.07.030_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930945","article-title":"The number of MRGPRX2-expressing cells is increased in skin lesions of patients with indolent systemic mastocytosis, but is not linked to symptom severity","volume":"13","author":"Pyatilova","year":"2022","journal-title":"Front Immunol"},{"issue":"14","key":"10.1016\/j.anai.2025.07.030_bib0037","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMp2031891","article-title":"Vancomycin infusion reaction - moving beyond \u201cred man syndrome","volume":"384","author":"Alvarez-Arango","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2025.07.030_bib0038","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000436969","article-title":"Management of anesthesia in adult and pediatric mastocytosis: a study of the Spanish network on mastocytosis (REMA) based on 726 anesthetic procedures","volume":"167","author":"Matito","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.07.030_bib0039","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00540-023-03228-x","article-title":"Perioperative management of mastocytosis","volume":"37","author":"Lau","year":"2023","journal-title":"J Anesth"},{"issue":"4","key":"10.1016\/j.anai.2025.07.030_bib0040","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.anai.2017.07.022","article-title":"Management around invasive procedures in mastocytosis: an update","volume":"119","author":"Hermans","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.07.030_bib0041","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.lpm.2016.02.024","article-title":"Epidemiology of perioperative anaphylaxis","volume":"45","author":"Mertes","year":"2016","journal-title":"Presse Med"},{"issue":"10","key":"10.1016\/j.anai.2025.07.030_bib0042","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/all.13820","article-title":"An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions","volume":"74","author":"Garvey","year":"2019","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2025.07.030_bib0043","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00000542-200109000-00019","article-title":"Different patterns of mast cell activation by muscle relaxants in human skin","volume":"95","author":"Koppert","year":"2001","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.anai.2025.07.030_bib0044","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/bja\/67.6.751","article-title":"General anaesthetics induce only histamine release selectively from human mast cells","volume":"67","author":"Stellato","year":"1991","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.anai.2025.07.030_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navin\u00e9s-Ferrer","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.anai.2025.07.030_bib0046","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00204-022-03402-2","article-title":"Opioid toxicity: histamine, hypersensitivity, and MRGPRX2","volume":"97","author":"Baldo","year":"2023","journal-title":"Arch Toxicol"},{"issue":"8","key":"10.1016\/j.anai.2025.07.030_bib0047","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1016\/j.jaip.2021.03.051","article-title":"Safety of local anesthesia and prevalence of hypersensitivity reactions in adult patients with clonal mast cell diseases: a retrospective single-center study","volume":"9","author":"Tanasi","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2025.07.030_bib0048","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/all.14656","article-title":"Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity","volume":"76","author":"Torres","year":"2021","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2025.07.030_bib0049","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2214\/AJR.07.2872","article-title":"Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy?","volume":"190","author":"Trcka","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.anai.2025.07.030_bib0050","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0310057X0903700415","article-title":"Anaphylactoid reaction to intravenous contrast in patient with systemic mastocytosis","volume":"37","author":"Weingarten","year":"2009","journal-title":"Anaesthesiol Intensive Care"},{"issue":"3","key":"10.1016\/j.anai.2025.07.030_bib0051","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2021.10.004","article-title":"Low risk of contrast media-induced hypersensitivity reactions in all subtypes of systemic mastocytosis","volume":"128","author":"Schwaab","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.07.030_bib0052","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/all.15996","article-title":"EAACI\/ENDA position paper on drug provocation testing","volume":"79","author":"Barbaud","year":"2024","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2025.07.030_bib0053","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaip.2024.10.044","article-title":"Safety and low incidence of anaphylaxis in performing oral drug and food challenges in mastocytosis","volume":"13","author":"Bent","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2025.07.030_bib0054","doi-asserted-by":"crossref","first-page":"315","DOI":"10.18176\/jiaci.0171","article-title":"Chemotherapy in mastocytosis: administration issues, hypersensitivity, and rapid drug desensitization","volume":"27","author":"Solano-Solares","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.07.030_bib0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.18176\/jiaci.0951","article-title":"Anaphylactic shock due to isatuximab and successful desensitization","volume":"34","author":"Torres G\u00f3rriz","year":"2024","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.07.030_bib0056","doi-asserted-by":"crossref","first-page":"214","DOI":"10.18176\/jiaci.0990","article-title":"Successful desensitization to isatuximab in a patient with refractory multiple myeloma and indolent systemic mastocytosis. Reply to: anaphylactic shock due to isatuximab and successful desensitization","volume":"34","author":"Hutten","year":"2024","journal-title":"J Investig Allergol Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062500403X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062500403X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:11:48Z","timestamp":1761819108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108112062500403X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S108112062500403X"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.07.030","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cell conditions and drug allergy","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}